Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000438000 | SCV000535875 | uncertain significance | not provided | 2017-01-12 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the MECP2 gene. The c.687 G>T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.687 G>T variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Several in-silico splice prediction models predict that c.687 G>T creates a cryptic acceptor site which may supplant the natural acceptor site and lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Additionally, this substitution occurs at a position that is not conserved. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Ambry Genetics | RCV002318492 | SCV000851267 | likely benign | Inborn genetic diseases | 2016-09-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001087926 | SCV001091253 | likely benign | Severe neonatal-onset encephalopathy with microcephaly | 2023-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000438000 | SCV004165064 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | MECP2: BP4, BP7 |
Prevention |
RCV003972661 | SCV004787387 | likely benign | MECP2-related condition | 2023-05-22 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |